Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $14.87 $19.38 Friday, 10th May 2024 RGNX stock ended at $15.44. This is 1.53% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 10.42% from a day low at $14.87 to a day high of $16.42.
90 days $14.87 $28.80
52 weeks $11.83 $28.80

Historical REGENXBIO Inc. prices

Date Open High Low Close Volume
Apr 05, 2024 $18.94 $19.87 $18.60 $19.17 411 366
Apr 04, 2024 $20.32 $20.77 $19.06 $19.15 612 186
Apr 03, 2024 $20.02 $20.65 $19.83 $20.25 518 225
Apr 02, 2024 $21.17 $21.19 $20.16 $20.29 525 477
Apr 01, 2024 $21.08 $21.57 $20.65 $21.53 529 509
Mar 28, 2024 $22.33 $22.42 $20.94 $21.07 487 038
Mar 27, 2024 $21.79 $22.34 $21.43 $22.18 457 108
Mar 26, 2024 $21.88 $22.30 $21.47 $21.67 328 348
Mar 25, 2024 $21.81 $22.12 $21.13 $21.59 279 425
Mar 22, 2024 $22.49 $22.81 $21.75 $21.78 270 502
Mar 21, 2024 $22.71 $23.14 $21.96 $22.50 566 382
Mar 20, 2024 $22.43 $22.98 $21.84 $22.51 468 447
Mar 19, 2024 $22.26 $22.96 $21.99 $22.39 540 496
Mar 18, 2024 $22.13 $22.61 $21.25 $22.33 459 344
Mar 15, 2024 $21.73 $22.84 $21.73 $22.19 1 028 171
Mar 14, 2024 $22.33 $22.51 $21.55 $21.85 463 325
Mar 13, 2024 $21.93 $23.07 $21.90 $22.47 509 164
Mar 12, 2024 $22.93 $23.33 $21.62 $21.98 757 049
Mar 11, 2024 $22.91 $23.57 $22.55 $22.85 648 235
Mar 08, 2024 $24.24 $24.25 $22.30 $22.75 1 543 083
Mar 07, 2024 $23.38 $23.70 $23.00 $23.23 2 117 951
Mar 06, 2024 $26.74 $27.16 $23.25 $24.00 1 166 053
Mar 05, 2024 $28.36 $28.80 $22.06 $24.61 2 802 660
Mar 04, 2024 $21.64 $21.79 $20.13 $21.36 865 967
Mar 01, 2024 $17.86 $21.69 $17.86 $21.19 1 488 743
Click to get the best stock tips daily for free!

About REGENXBIO Inc.

REGENXBIO. REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's lead product candidate is RGX-314, wh... RGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT